The World Heart Federation Emerging Leaders program wel-comes the 2017 cohort of emerging leaders!
- Cardiovascular disease (CVD) is the world's number one killer, causing 17.5 million deaths per year
- Access to essential medicines to prevent and treat CVD is worryingly low, particularly in low- and middle-income countries
2017 marks the fourth year of the World Heart Federation Emerging Leaders programme and will focus on access to essential medicines for cardiovascular diseases. Despite the availability for decades of evidence-based medicines to prevent and treat CVD, their use is still very low.
Access to essential CVD medicines is worryingly low globally and particularly in low- and middle-income countries (LMICs), where some of the barriers to CVD medicines access include poor access to health care facilities, low availability, poor quality of medication and unaffordability. This places a heavy financial burden on individuals and households, and creates an urgent need to find innovative ways - from policies through to models of care - to improve access to these live-saving medications.
Launched by former World Heart President Salim Yusuf, the 2017 World Heart Federation Emerging Leaders cohort will build capacity for research and advocacy to support projects which harness local knowledge and global expertise to improve access to medicines through stronger policies and strengthened programmes.
Emerging leader and Faculty Biographies can be viewed here:
VENUE: Hatter Institute for Cardiovascular Research in Africa- 5th floor Chris Barnard Building
Faculty of Health Sciences, University of Cape Town, South Africa
The programme
|
Monday, 19 June 2017
|
||
|
9:00 – 9:15 |
Background: Program and seminar overview |
Prof Mark Huffman Northwestern University, USA |
|
9:15 – 10:15 |
Background: World Heart Federation, Emerging Leaders, and Roadmaps for improving access to essential cardiovascular medicines (including framework on physical accessibility, affordability, acceptability) |
Prof David Wood, Imperial College, President World Heart Federation
Prof Pablo Perel, London School of Hygiene & Tropical Medicine, World Heart Federation |
|
10:15 – 10:45 |
Tea / Coffee break |
|
|
10:45 – 11:30 |
Background: Impact of socioeconomic status, ethnicity, and urbanization on risk factor profiles of cardiovascular disease in Africa: Implications for essential care and medicines |
Prof. Karen Sliwa, HICRA, University of Cape Town, President Elect World Heart Federation |
|
11:30 – 14:30 |
Break |
|
|
2:30 – 3:30 |
Health policy: Penicillin as an essential medicine for rheumatic heart disease primary and secondary prevention |
Prof Bongani Mayosi, dean, Faculty of Health Sciences, University of Cape Town
|
|
3:30 – 3:45 |
Tea/coffee break |
|
|
3:45 – 5:00 |
Plenary: Essential medicines and care for improving the cardiovascular health of all South Africans and for achieving the World Health Organization’s 25 x 25 goal Panel with government, non-governmental organizations, private industry, practitioners, and researchers |
Moderators: Jean-Luc Eiselé, Karen Sliwa |
|
Tuesday, 20 June 2017
|
||
|
9:00 – 9:45 |
Implementation science: Translating point-of-care strategies to assess adherence to essential medicines from HIV to CVD |
Prof. Gary Maartens, Pharmacology, University of Cape Town |
|
9:45 – 10:15 |
Advocacy and activism: Principles for advocacy to improve access to essential medicines |
Jeremiah Mwangi, World Heart Federation |
|
10:15 – 10:45 |
Tea/coffee break |
|
|
10:45 – 12:15 |
Health policy: Access to Medicines Initiative |
Nathan Mulure, Novartis East Africa |
|
Wednesday, 21 June 2017
|
||
|
9:00 – 9:45 |
Health systems: Achieving good health at low cost |
Prof. Marc Blockman, University of Cape Town |